MA:NYSEMastercard Incorporated Analysis
Data as of 2026-04-16 - not real-time
$519.96
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Mastercard (MA) trades at $519.96, marginally above its DCF fair value of $503, and sits between its 20‑day SMA ($499.6) and 50‑day SMA ($513.0) while still below the 200‑day SMA ($551.3), indicating a short‑term pull‑back within a longer‑term uptrend. The RSI of 58.7 suggests modest upward momentum but not overbought, and the MACD histogram (+3.4) signals a bullish crossover despite a bearish overall trend direction. Volume is decreasing, and the stock is testing resistance around $522.4 with support near $480.5, framing a tight trading range. Fundamentally, MA delivers strong earnings growth (17.6% revenue growth, forward EPS up 37% YoY) and high profitability (57.7% operating margin), but its PE of 31.5× far exceeds the industry average of 17.6×, implying an overvalued valuation today.
Recent material news includes the $1.8 B BVNK acquisition, a successful pilot of authenticated agentic transactions in Malaysia, and ongoing litigation over interchange fees, which could impact margins. The dividend remains modest at 0.67% with an 18% payout ratio, supported by robust cash flow. Analyst sentiment is heavily bullish (strong‑buy, median target $665), and the Fear & Greed Index at 88.98 reflects “Extreme Greed,” suggesting heightened market enthusiasm.
Recent material news includes the $1.8 B BVNK acquisition, a successful pilot of authenticated agentic transactions in Malaysia, and ongoing litigation over interchange fees, which could impact margins. The dividend remains modest at 0.67% with an 18% payout ratio, supported by robust cash flow. Analyst sentiment is heavily bullish (strong‑buy, median target $665), and the Fear & Greed Index at 88.98 reflects “Extreme Greed,” suggesting heightened market enthusiasm.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance with decreasing volume
- Bearish trend direction despite bullish MACD signal
- Potential short‑term volatility (23% 30‑day)
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong earnings growth and high operating margins
- Strategic acquisition (BVNK) expanding digital capabilities
- Analyst consensus strong‑buy with median price target $665
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend supported by cash flow
- Global network reducing geographic concentration risk
- Long‑run upside potential (~26% above current price) per DCF and analyst targets
Key Metrics & Analysis
Financial Health
Revenue Growth17.60%
Profit Margin45.65%
P/E Ratio31.5
ROE209.91%
ROA23.72%
Debt/Equity256.04
P/B Ratio60.1
Op. Cash Flow$17.6B
Free Cash Flow$16.3B
Industry P/E17.6
Technical Analysis
TrendBearish
RSI58.7
Support$480.50
Resistance$522.43
MA 20$499.63
MA 50$513.01
MA 200$551.28
MACDBullish
VolumeDecreasing
Fear & Greed Index88.98
Valuation
Fair Value$503.56
Target Price$654.66
Upside/Downside25.91%
GradeOvervalued
TypeGrowth
Dividend Yield0.67%
Risk Assessment
Beta0.71
Volatility23.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.